Fatigue News and Research

RSS

AAOPD and Homeland HealthCare enter partnership

The American Association of Professional Drivers (AAOPD) announced today a partnership with Homeland HealthCare Inc., a third party administrator of supplemental insurance plans based in Allen, Texas, and a member of Inc. Magazine's Fastest Growing Private Companies in the US. The announcement commemorates National Truck Driver Appreciation Week (September 19 – 25) honoring America's 3.2 million truckers.

23 Sep 2010

Implantation of new bioprosthetic-tissue valve in patients with severe aortic stenosis saves lives

Implantation of a new bioprosthetic-tissue valve into the hearts of patients who have severe aortic stenosis and are too sick or too old for open-heart surgery has been found to both save lives and improve the quality of those lives, according to a new multicenter study, to be published online at 2 p.m. Pacific time today in the New England Journal of Medicine.

23 Sep 2010

FDA approves fingolimod drug for multiple sclerosis

The first oral medication for multiple sclerosis was approved today by the Food & Drug Administration. Physicians praised the decision to approve the drug, called fingolimod, saying it would give multiple sclerosis patients new options for treatment.

23 Sep 2010

Clinton Global Initiative meeting kicks off, U.S. will commit to Clean Cookstove project

"World leaders, CEOs, non-governmental organizations and philanthropists" are gathering this week at the Clinton Global Initiative (CGI) annual meeting, "[t]imed to coincide with the beginning of the United Nations General Assembly," WNYC News reports (Herman, 9/20).

22 Sep 2010

Annals of Internal Medicine publishes GRACE study data on HIV therapy

Data from the GRACE study will be published in the September 21st issue of the Annals of Internal Medicine. GRACE is the largest-ever study of treatment experienced adult women with HIV-1 to examine gender differences in response to HIV therapy. Sponsored by Tibotec Therapeutics Clinical Affairs, a division of Centocor Ortho Biotech Services, LLC, the GRACE study enrolled 67 percent women, demonstrating that it is possible to recruit large numbers of women into U.S.-based HIV treatment studies.

21 Sep 2010

LA surgeon develops minimally invasive approach to remove pineal tumors

One of the most difficult-to-remove tumors located deep in the midbrain area can now be safely excised thanks to the work of one Los Angeles surgeon. Hrayr Shahinian, M.D., medical director of The Skull Base Institute in Los Angeles, has developed a minimally invasive approach to removing pineal tumors so called as they are shaped like pine cones.

21 Sep 2010

FG-4592 oral anemia therapy receives CTA approval from SFDA

FibroGen, Inc., today announced that its investigational oral anemia therapy, FG-4592, received Clinical Trial Application (CTA) approval from the Chinese State Food and Drug Administration (SFDA) to commence clinical development for the treatment of anemia associated with chronic kidney disease (CKD) in the People's Republic of China.

21 Sep 2010

Corindus announces clinical results of CorPath 200 System

Corindus Vascular Robotics announced the results of the first clinical study of the CorPath 200 System and invites attendees of the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference (September 21-25 in Washington, DC) to experience firsthand the CorPath 200 System.

21 Sep 2010

Society for Vascular Nursing partners with local hospitals to create P.A.D awareness

Approximately 9 million Americans have peripheral arterial disease (P.A.D.), a common and dangerous vascular disease that can lead to heart attack, stroke, amputation and death. Unfortunately, many with the disease do not even know they have it. September is P.A.D. Awareness Month, and the P.A.D. Coalition and the Society for Vascular Nursing are joining forces with local hospitals to inform Americans about the risk factors, warning signs and consequences of P.A.D.

17 Sep 2010

Hormone Foundation produces two fact sheets to dispel myths of adrenal fatigue, Wilson's temperature syndrome

The Hormone Foundation, the public education affiliate of The Endocrine Society, has produced two new fact sheets to dispel myths about so-called "diseases" popularized through the Internet: adrenal fatigue and Wilson's temperature syndrome.

16 Sep 2010

Incyte Corporation publishes clinical trial data of INCB18424 drug for myelofibrosis treatment

Incyte Corporation, Results from a Phase I/II study of Incyte's janus kinase (JAK) inhibitor with the investigational name INCB18424 (also known as INCB018424 and INC424) were published today in The New England Journal of Medicine, demonstrating marked and durable clinical benefits in patients with myelofibrosis.

16 Sep 2010

Physically active adolescents with fibromyalgia report lower levels of pain, disability: Study

Adolescents with fibromyalgia who are physically active report lower levels of pain and disability, according to findings of a multicenter study published in The Journal of Pain, published by the American Pain Society, ampainsoc.org.

16 Sep 2010

New computerized catheter makes surgical treatment of atrial fibrillation faster, cheaper and more effective

Atrial fibrillation is a heart disorder that affects more than two million Americans, and is considered a key contributor to blood clots and stroke. Now researchers from North Carolina State University are developing a new computerized catheter that could make the surgical treatment of atrial fibrillation faster, cheaper and more effective - while significantly decreasing radiation exposure related to the treatment.

16 Sep 2010

JAK oral medication produces lasting relief for patients with myelofibrosis: Researchers

An oral medication produces significant and lasting relief for patients with myelofibrosis, a debilitating and lethal bone marrow disorder, researchers at The University of Texas MD Anderson Cancer Center report in the Sept. 16 New England Journal of Medicine.

16 Sep 2010

BioCryst reports results from forodesine studies for CTCL and CLL

BioCryst Pharmaceuticals, Inc. announced preliminary top-line results from its multinational, open-label, single-arm trial evaluating 200 mg once-daily oral forodesine in the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL), as well as interim results from the Company's exploratory Phase 2 study to investigate the efficacy and safety of 200 mg twice-daily oral forodesine as monotherapy for chronic lymphocytic leukemia (CLL).

15 Sep 2010

Mechanism linking brain activity to sleep discovered

Washington State University researchers have discovered the mechanism by which the brain switches from a wakeful to a sleeping state. The finding clears the way for a suite of discoveries, from sleeping aids to treatments for stroke and other brain injuries.

15 Sep 2010

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences, Inc. today announced Phase II clinical trial results showing that its investigational fixed-dose, single-tablet "Quad" regimen of elvitegravir, cobicistat and Truvada (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection maintained a high rate of virologic suppression through 48 weeks, exhibiting antiretroviral activity comparable to that of Atripla(efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

14 Sep 2010

New electronic sensor detects pressure exerted by 20 milligram bluebottle fly carcass

The light, tickling tread of a pesky fly landing on your face may strike most of us as one of the most aggravating of life's small annoyances. But for scientists working to develop pressure sensors for artificial skin for use on prosthetic limbs or robots, skin sensitive enough to feel the tickle of fly feet would be a huge advance. Now Stanford researchers have built such a sensor.

14 Sep 2010

Leukemia survivor to meet donor of bone marrow transplant

Ann Marie Del Fiacco, a 38-year-old Berwyn mother of two, owes her life to a stranger who volunteered to be a donor for her life-saving bone marrow transplant.

13 Sep 2010

Candida Force program of detoxification and dietary recommendations effective for weight reduction

Early this month, the cover of First for Women magazine stopped Kathleen Kalaf in her tracks. The magazine featured an article about the connection between systemic Candida, or yeast overgrowth, and fat.

10 Sep 2010

Fatigue News and Research

AAOPD and Homeland HealthCare enter partnership

Implantation of new bioprosthetic-tissue valve in patients with severe aortic stenosis saves lives

FDA approves fingolimod drug for multiple sclerosis

Clinton Global Initiative meeting kicks off, U.S. will commit to Clean Cookstove project

Annals of Internal Medicine publishes GRACE study data on HIV therapy

LA surgeon develops minimally invasive approach to remove pineal tumors

FG-4592 oral anemia therapy receives CTA approval from SFDA

Corindus announces clinical results of CorPath 200 System

Society for Vascular Nursing partners with local hospitals to create P.A.D awareness

Hormone Foundation produces two fact sheets to dispel myths of adrenal fatigue, Wilson's temperature syndrome

Incyte Corporation publishes clinical trial data of INCB18424 drug for myelofibrosis treatment

Physically active adolescents with fibromyalgia report lower levels of pain, disability: Study

New computerized catheter makes surgical treatment of atrial fibrillation faster, cheaper and more effective

JAK oral medication produces lasting relief for patients with myelofibrosis: Researchers

BioCryst reports results from forodesine studies for CTCL and CLL

Mechanism linking brain activity to sleep discovered

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

New electronic sensor detects pressure exerted by 20 milligram bluebottle fly carcass

Leukemia survivor to meet donor of bone marrow transplant

Candida Force program of detoxification and dietary recommendations effective for weight reduction

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News